vimarsana.com

Latest Breaking News On - Maryt conway - Page 7 : vimarsana.com

Oxurion Receives EUR 1 5 Million under Amended Atlas Funding Program; Total of EUR 3 5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial

25.10.2023 - Leuven, BELGIUM, Boston, MA, US – October 25, 2023 – 8 am CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal .

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Information on the Total Number of Voting Rights

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.